Quantum Leap Healthcare Collaborative

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

Rita Nanda, Minetta C. Liu, Christina Yau et al. · JAMA Oncology · 2020 · 706 citations · Full text

Medicine, Oncology, Pharmacology +16

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele et al. · New England Journal of Medicine · 2016 · 555 citations · Full text

Medicine, Oncology, Pharmacology +13

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee et al. · New England Journal of Medicine · 2016 · 460 citations · Full text

Medicine, Oncology, Pharmacology +17

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

Mark Jesus M. Magbanua, Lamorna Brown Swigart, H.-T. Wu et al. · Annals of Oncology · 2020 · 438 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Lajos Pusztai, Christina Yau, Denise M. Wolf et al. · Cancer Cell · 2021 · 330 citations · Full text

Medicine, Oncology, Pharmacology +10